| Q92510341 | Bone Marrow Stromal Cells Alleviate Secondary Damage in the Substantia Nigra After Focal Cerebral Infarction in Rats |
| Q37351594 | Chemokines and neurodegeneration in the early stage of experimental ischemic stroke |
| Q40952165 | Cytoprotection against Hypoxic and/or MPP⁺ Injury: Effect of δ-Opioid Receptor Activation on Caspase 3. |
| Q26830147 | Deep brain stimulation: are astrocytes a key driver behind the scene? |
| Q48302288 | Determination of Brain-Regional Blood Perfusion and Endogenous cPKCγ Impact on Ischemic Vulnerability of Mice with Global Ischemia |
| Q36657091 | Dynamic secondary degeneration in the spinal cord and ventral root after a focal cerebral infarction among hypertensive rats |
| Q33706292 | Electroacupuncture attenuates cervical spinal cord injury following cerebral ischemia/reperfusion in stroke-prone renovascular hypertensive rats |
| Q38587925 | Endogenous recovery after brain damage: molecular mechanisms that balance neuronal life/death fate. |
| Q55220148 | Exogenous α-synuclein hinders synaptic communication in cultured cortical primary rat neurons. |
| Q43129915 | Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction. |
| Q64084265 | Fluoxetine suppresses inflammatory reaction in microglia under OGD/R challenge via modulation of NF-κB signaling |
| Q55024687 | Inhibition of Cathepsins B Induces Neuroprotection Against Secondary Degeneration in Ipsilateral Substantia Nigra After Focal Cortical Infarction in Adult Male Rats. |
| Q91033666 | Juvenile mild traumatic brain injury elicits distinct spatiotemporal astrocyte responses |
| Q41848302 | MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for neuroprotection. |
| Q33727623 | Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia |
| Q64779041 | Mitochondrial and calcium perturbations in rat CNS neurons induce calpain-cleavage of Parkin: Phosphatase inhibition stabilizes pSer65Parkin reducing its calpain-cleavage |
| Q34933261 | Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration |
| Q92535648 | Neuroprotective Effects of Salidroside on Cerebral Ischemia/Reperfusion-Induced Behavioral Impairment Involves the Dopaminergic System |
| Q48511919 | Normalization of T2 relaxation time and apparent diffusion coefficient in relation to the inflammatory changes in the substantia nigra of rats with focal cerebral ischemia |
| Q41769727 | PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. |
| Q38366399 | Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke |
| Q57176938 | The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q90749822 | The delta-opioid receptor and Parkinson's disease |
| Q24338953 | δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP(+) and/or hypoxia |